Drug
Almotriptan clinical trials
How studies write it
Studies that test it under each name
Studies by the year they started
7 studies that test it; most in 2004 (2)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 2 |
| 2007 | 1 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 2
Janssen-Ortho LLC (4) · Ortho-McNeil Neurologics, Inc. (1) · Messoud Ashina, MD (1) · The New England Center for Headache, P.C. (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses almotriptan is read from its arms, and is right about nine times in ten.
Testing it · 7
- Evaluation of the Efficacy of Almotriptan and Ubrogepant for the Acute Treatment of MigraineTerminatedPhase 4Messoud Ashina, MDNCT05214001Written as Almotriptan 12.5 Mg Oral Tablet
- A 1-year Study in Adolescents to Assess the Long-term Safety of Almotriptan Malate When Treating Their Migraine HeadachesCompletedPhase 3Janssen-Ortho LLCNCT00257010Written as Almotriptan Malate
- The Effectiveness of Almotriptan Malate (AXERT®) 12.5 Milligrams When Taken at the Onset of Migraine PainCompletedPhase 4Ortho-McNeil Neurologics, Inc.NCT00212823Written as almotriptan malate
- Potential Impact (Benefit) of Preventative Treatment With Topamax on the Effectiveness of Axert in the Acute Treatment of MigraineCompletedPhase 4Janssen-Ortho LLCNCT00210496Written as topiramate; almotriptan malate
- A Study of the Effectiveness and Safety of Almotriptan Versus Placebo in the Treatment of Migraine HeadacheCompletedPhase 4Janssen-Ortho LLCNCT00210509Written as almotriptan malate
- A Study of 3 Dosage Strengths of Almotriptan Malate (AXERT®) in the Treatment of Acute Migraine in AdolescentsCompletedPhase 3Janssen-Ortho LLCNCT00210483Written as almotriptan malate
- Detoxification and Treatment of Subjects With Medication Overuse HeadacheStatus unknownPhase 4The New England Center for Headache, P.C.NCT00432549Written as Almotriptan
Codes
What other systems call almotriptan · ClinicalTrials.gg INT004239
- MeSH (NLM) C409045almotriptanConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 1O4XL5SN61ALMOTRIPTANConfirmed FDA, NLM, Wikidata
- RxNorm 279645Confirmed FDA, Wikidata
- Wikidata Q409729almotriptanConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C65224AlmotriptanOne source FDA
- DrugBank DB00918One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C409045 | almotriptan | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 1O4XL5SN61 | ALMOTRIPTAN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 279645 | — | Confirmed FDA, Wikidata |
| Wikidata | Q409729 | almotriptan | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C65224 | Almotriptan | One source FDA |
| DrugBank | DB00918 | — | One source Wikidata |
Also registered as almotriptan malate (UNII PJP312605E · RxNorm 283792).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.